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Immunoglobulin A plays an important role inimmune responses of the gastrointestinal tract large-
ly because it is present in mucosal secretions at con-
centrations far in excess of other immunoglobulin
classes.1 It prevents colonization and invasion by
microorganisms, neutralizes bacterial toxins, and elim-
inates antigen from the lamina propria via transport of
immune complexes.2 Most of this IgA is locally pro-
duced by IgA+ plasma cells within the lamina propria3
and is transported across the epithelial barrier by the
polymeric immunoglobulin receptors (pIgRs).
Critical to this transport mechanism is the presence of
the J-chain that links the IgA monomers to form
dimeric IgA.4 A portion of the pIgR, termed the secre-
tory component, remains bound to the dimeric IgA
after proteolytic cleavage of the pIgR from the apical
membrane of the enterocyte, forming secretory IgA.5
The secretory component increases the resistance of
IgA to proteases present within mucosal secretions.6–8
Selective IgA deficiency is the most common pri-
mary immunodeficiency in humans and affects
approximately 1 in every 500 Caucasians.9 Human IgA
deficiency has been associated with several diseases
including allergies, autoimmunity, recurrent respirato-
ry tract infections, and gastrointestinal tract disease,
but most IgA-deficient humans do not have serious
associated complications and are clinically normal.10
Immunoglobulin A knockout mice have a decreased
ability to clear infection with Giardia spp, compared
with wild-type mice.11
Secretory component deficiency has been associat-
ed with chronic gastrointestinal tract disease and mal-
absorption in humans.12,13 These reports noted a
decrease in both mucosal IgA and free secretory com-
ponent in affected individuals, compared with clinical-
ly normal humans.12,13 There is some dispute as to
whether primary pIgR deficiency has been convincing-
ly documented in humans, as some affected individu-
als may have pIgR deficiency secondary to the presence
of other disease conditions.14,15
Compared with wild-type mice, polymeric
immunoglobulin receptor knockout mice have a
decreased concentration of IgA within intestinal secre-
tions despite the presence of normal or increased num-
bers of IgA+ plasma cells in the lamina propria.16,17
Similarly, J-chain knockout mice also have a decreased
concentration of IgA in bile,18 feces,18 and intestinal
secretions19; the IgA present within these secretions
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Objective—To examine the difference in expression
of messenger RNA (mRNA) transcripts for polymeric
immunoglobulin receptor (pIgR), α-chain, and J-chain
determined by use of quantitative real-time reverse
transcription-polymerase chain reaction (QRT-PCR)
assays in duodenal biopsy specimens obtained from
dogs with and without chronic diarrhea.
Sample Population—Biopsy specimens of the prox-
imal portion of the duodenum were obtained endo-
scopically from 39 dogs evaluated because of chronic
diarrhea (12 German Shepherd Dogs and 27 non-
German Shepherd Dog breeds); specimens were also
obtained from a control group of 7 dogs evaluated
because of other gastrointestinal tract diseases and 2
dogs that were euthanatized as a result of nongas-
trointestinal tract disease.
Procedure—Dogs were anesthetized, and multiple
mucosal biopsy specimens were obtained endoscop-
ically at the level of the caudal duodenal flexure by
use of biopsy forceps; in 2 control dogs, samples
were obtained from the descending duodenum with-
in 5 minutes of euthanasia. One-step QRT-PCR was
used to quantify the level of expression of transcripts
for the housekeeper gene glyceraldehyde-3-phos-
phate dehydrogenase, pIgR, α-chain, and J-chain in
duodenal mucosal tissue.
Results—There was no significant difference in the level
of expression of any transcript among non-German
Shepherd Dog breeds without diarrhea (control group),
non-German Shepherd Dog breeds with chronic diar-
rhea, and German Shepherd Dogs with chronic diarrhea.
Conclusions and Clinical Relevance—Results indi-
cated that the susceptibility of German Shepherd
Dogs to chronic diarrhea is not a result of simple fail-
ure of transcription of the key genes that encode mol-
ecules involved in mucosal IgA secretion. (Am J Vet
Res 2005;66:11–16) 
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was not polymeric and was not associated with the
secretory component.20 Furthermore, the J-chain-defi-
cient IgA from J-chain knockout mice could not asso-
ciate with pIgR present on Madin-Darby canine kidney
cells transfected with the receptor.18
German Shepherd Dogs are susceptible to several
inflammatory or immune-mediated diseases including
disseminated aspergillosis,21 deep pyoderma,22–25 anal
furunculosis,26,27 small intestinal bacterial over-
growth,28–32 and inflammatory bowel disease.33
Studies29,32,34,35 of serum IgA concentrations in German
Shepherd Dogs with or without disease have revealed a
decreased concentration relative to that in control pop-
ulations. Decreased mucosal immunity associated with
this apparent deficiency in serum IgA was implicated
as a factor that predisposed dogs of this breed to small
intestinal bacterial overgrowth.29 In a report of another
study,36 the concentration of IgA in duodenal mucosal
explant culture supernatants from German Shepherd
Dogs with normal numbers of IgA+ lamina propria
plasma cells was decreased, compared with non-
German Shepherd Dog breeds. A defect in the trans-
port of IgA across the epithelial barrier, or low IgA pro-
duction by the plasma cells, may be responsible for this
decreased mucosal IgA secretion in German Shepherd
Dogs, which in turn may play a role in the apparent
susceptibility of dogs of this breed to chronic diarrhea.
The purpose of the study reported here was to
examine the difference in expression of messenger
RNA (mRNA) transcripts for pIgR, α-chain, and J-
chain determined by use of quantitative real-time
reverse-transcription polymerase chain reaction
(QRT-PCR) in duodenal biopsy specimens obtained
from dogs with and without chronic diarrhea. Our
intent was to assess the role (if any) of deficient intesti-
nal IgA secretion in the pathogenesis of chronic
enteropathies in dogs.
Materials and Methods
Dogs—Endoscopic biopsy specimens of duodenal
mucosa were obtained from 39 dogs that were evaluated at
the School of Clinical Veterinary Science, University of
Bristol, because of chronic diarrhea. Because of limited access
to clinically normal dogs, control biopsy specimens of duo-
denal mucosa were obtained from 7 dogs that did not have
diarrhea but were undergoing endoscopy for investigation of
primary gastroesophageal disease and from 2 dogs that were
euthanatized with their owners’ permission for clinical rea-
sons relating to nongastrointestinal tract disease and were
examined postmortem.
Dogs were separated into 3 groups on the basis of breed
and clinical signs. A control group (group 1) comprised 9
dogs without chronic diarrhea for which histologic examina-
tion of contemporaneously collected biopsy specimens of
duodenal mucosa revealed no abnormalities; this group
included biopsy specimens obtained from 2 dogs post-
mortem. Breeds represented in the control group included 1
each of Rough Collie, Lurcher, Greyhound, West Highland
White Terrier, Whippet, Golden Retriever, Staffordshire Bull
Terrier, Flat-Coated Retriever, and crossbred. The median age
of dogs in the control group was 24 months (range, 6 to 96
months), and there were 4 females (2 neutered) and 5 males
(4 neutered). The diagnoses for the 7 dogs from which biop-
sy specimens were obtained endoscopically were chronic gas-
tritis (n = 6) and megaesophagus (1).
Two further groups were composed of dogs with chron-
ic diarrhea at the time of evaluation. Group 2 consisted of 27
dogs of non-German Shepherd Dog breeds; the median age of
these dogs was 36 months (range, 6 to 144 months), and
there were 12 females (7 neutered) and 15 males (6
neutered). Breeds represented in group 2 included crossbred
(n = 5), Labrador Retriever (4), Golden Retriever (4), Boxer
(2), Border Collie (2), and 1 each of Cocker Spaniel, Cavalier
King Charles Spaniel, Lurcher, Old English Sheepdog,
Rottweiler, Shetland Sheepdog, English Springer Spaniel,
Staffordshire Bull Terrier, Tibetan Terrier, and West Highland
White Terrier. Group 3 consisted of 12 German Shepherd
Dogs; the median age of these dogs was 36 months (range, 12
to 132), and there were 5 females (2 neutered) and 7 males
(3 neutered).
Sample collection—Dogs were prepared for endoscopy
by withholding food for 18 to 24 hours. Dogs were anes-
thetized, and gastroduodenoscopy was performed by use of a
flexible video endoscope.a Multiple mucosal biopsy speci-
mens were obtained at the level of the caudal duodenal flex-
ure by use of biopsy forcepsb; collection of biopsy specimens
was generally performed by 1 endoscopist (EJH). Samples for
histologic examination were placed in neutral-buffered 10%
formalin. Biopsy specimens for mRNA analysis were placed
in a 1.0-mL cryotube,c snap-frozen in liquid nitrogen, and
stored at –70oC.
In 2 control dogs, samples were obtained from the
descending duodenum within 5 minutes of euthanasia
(achieved via IV administration of an overdose of pentobar-
bitone). Samples were obtained by use of biopsy forceps from
an area equivalent to that used to provide the vital samples,
snap frozen, and stored as described. Full-thickness samples
were collected for histologic examination.
Primer and probe design—The primerd and probee
sequences for the quantification of glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH), pIgR, and J-chain are the
same as those used previously (Appendix).37 A primer set was
designed against canine immunoglobulin alpha heavy chain
(α-chain) by use of the available GenBank sequence (acces-
sion No. L36871). Primer and probe sets were designed as
described previously.37 Hydrolysis probes were used in the
quantification of pIgR and G3PDH; SYBR Green I was used
for J-chain and α-chain quantification.
RNA isolation—All samples were coded prior to RNA
extraction, and subsequent analysis was performed without
personnel being aware of which dog was the source of each
sample. Two biopsy specimens obtained endoscopically
(total tissue mass, 8 to 18 mg) were added to a mechanical
homogenization tubef containing 800 µL of lysis bufferg and
processed for 45 seconds at 6.0 m/s to homogenize the tis-
sues. A 175-µL aliquot of this lysate was processed through a
spin-column purification system, which included an integral
on-column DNase digestion step.g Samples were processed
according to the manufacturer’s protocol, except that the
RNA was eluted into 200 µL of nuclease-free water. A nega-
tive control of nuclease-free water was included.
QRT-PCR assay—Gene-specific QRT-PCR amplification
of G3PDH, pIgR, J-chain, and α-chain was performed by use
of 5 µL of total RNA in each reaction.h Primers and probes
(for G3PDH and pIgR analysis) were used at a concentration
of 200nM and SYBR Green I (for J-chain and α-chain analy-
sis) at a concentration of 1:100,000.i All reactants, with the
exception of the forward primer, were mixed together as a
master mix; aliquots were added to either a 24- or 96-well
PCR platej prior to addition of 5 µL of the sample RNA to
make a final volume of 25 µL. No-RT control reactions were
made by substituting the RT enzyme mix with 2 units of Taq
12 AJVR, Vol 66, No. 1, January 2005
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DNA polymerase.k Each sample was run in triplicate, in addi-
tion to the No-RT controls for G3PDH (n = 3), α-chain (1),
pIgR (1) and J-chain (1). The reactions for each target were
performed in the same plate. Test samples were randomly
grouped prior to analysis.
The RT reaction was performed in a thermocyclerl by
incubation at 50oC for 15 minutes (G3PDH, J-chain, and
pIgR) or 55oC for 20 minutes (α-chain). The reactions were
quenched on ice, and 200nM of the forward primer was added
in a suitable volume of RT buffer to increase the reaction vol-
ume to 30 µL because this procedure decreases primer-dimer
formation associated with RT enzymes.38 The plates were
sealed and the protocol completed by incubation at 95oC for
5 minutes and then 45 cycles each of 95oC for 5 seconds and
60oC (62°C for J-chain) for 10 seconds, during which the flu-
orescence data were collected. The threshold cycle (Ct value)
was calculated as the cycle when the fluorescence of the sam-
ple exceeded a threshold level corresponding to 10 SDs from
the mean of the baseline fluorescence.
A melt curve was produced for the α-chain and J-chain
assays by heating the samples from 75oC to 95oC in 0.4oC incre-
ments with a dwell time at each temperature of 10 seconds dur-
ing which the fluorescence data were collected. The melting
temperatures of the products were compared with those
obtained from amplification of gel-purified α-chain or J-chain
PCR products,m which had been sequenced to check specificity.
For samples with multiple products or with incorrect melting
temperature, the Ct values were discarded. Negative results
were confirmed by repetition of the QRT-PCR procedure.
Reaction efficiency—The assays for the quantification
of pIgR, J-chain, and G3PDH have previously been shown to
be > 95% efficient when tested against a 10-fold dilution
series of RNA.37 A 10-fold serial RNA dilution curve was pro-
duced in triplicate to calculate the QRT-PCR reaction effi-
ciency for the α-chain assay. A master mix was prepared, and
aliquots were added to the PCR plate prior to addition of the
template into each reaction tube individually. A graph of
threshold cycle (Ct) versus log10 relative copy number of the
sample from the dilution series was produced. The slope of
this graph was used to determine the reaction efficiency by
use of the following equation (Figure 1):
Efficiency = [10(–1/slope)] – 1.
Relative copy number calculation—To normalize all
threshold cycle measurements for the other products, G3PDH
was used as a housekeeper gene. As reported previously,37
genomic contamination of the RNA samples for G3PDH
occurred, despite DNase treatment. The difference in the mean
Ct value for the RT and No-RT samples was calculated. The dif-
ference between these measurements was a minimum of 5
cycles, which indicated that the genomic DNA contributed < 3%
of the template of the QRT-PCR reaction (eg, 1/25 X 100).
Therefore, the G3PDH QRT-PCR measurements were used for
normalization of the measurements for the other gene products.
The G3PDH correction value was determined by nor-
malizing all measurements to a Ct value of 20 to provide a
G3PDH correction value by use of the following equation:
G3PDH correction value = (20 – Mean Ct value of the G3PDH
QRT-PCR assay).
The corrected target Ct measurement for each gene
product was then calculated by adding the G3PDH correc-
tion value to the mean Ct value of the replicates for each of
the gene targets.
Corrected target Ct value = Mean Ct + G3PDH correction
value.
The QRT-PCR was run for a maximum of 45 cycles;
therefore, a relative copy number for a sample with this value
was set as 1. Samples with no measured Ct value were
assigned a value of 0. All corrected Ct values were < 45.
Because all the reactions were approximately 100% efficient,
the relative number of gene copies in the sample was calcu-
lated by use of the following equation:
Relative copy number = 2∆Ct (for a 100% efficient reaction),
where ∆Ct = 45 – corrected target Ct value of the sample.
Statistical analyses—The relative copy number of each
gene product was used as the basis for all comparisons. The
results were assessed for normality both before and after
transformation by use of the Kolmogorov-Smirnov test.
Possible confounding effects of age, sex, and neutering were
assessed for each gene target. The data were not normally dis-
tributed either before or after transformation; therefore, the
nonparametric Kruskal-Wallis analysis of variance and the
Spearman rank correlation were used as appropriate for all
comparisons. Posttest analysis was performed by use of the
Mann-Whitney test. The level of significance was set to P <
0.05 for all analyses.
Results
QRT-PCR assay optimization—A range of primer
annealing temperatures was tested for the α-chain
primer set in the range of 55o to 70oC by use of the gra-
dient function on the thermocycler. The reaction was
efficient at 60oC with no improvement in sensitivity at
higher or lower annealing temperatures. The magne-
sium sulfate concentration was not increased from
3mM in the QRT-PCR assays to minimize primer-dimer
formation.38 The primer set used to quantify α-chain
mRNA in the present study was equally able to detect
the allelic variants of the canine alpha heavy chain
gene39; these variants differ in the hinge encoding
region of the second exon, which was amplified by this
primer set (data not shown).
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Figure 1—Standard dilution curve (threshold cycle [Ct] vs log10
relative copy number of the sample) for the quantitative real-
time reverse transcription-polymerase chain reaction (QRT-PCR)
assay for α-chain produced from a triplicate reaction for α-chain
with a 10-fold serial dilution of RNA isolated from duodenal
mucosal biopsy specimens obtained from a dog. The slope of
the graph was used to determine reaction efficiency by use of
the following equation: (10[-1/slope]) – 1. y = The equation of the
standard curve. R 2 = Correlation coefficient.
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Clinical samples—The 3 specific gene targets
could be quantified in all samples with the exception
of J-chain, which could not be quantified in 1 RNA
sample although the other 2 targets, as well as
G3PDH, were detected. All copy numbers were calcu-
lated so that a corrected Ct value of 45 corresponded
to a relative copy number of 1; this allowed the rela-
tive abundances of the templates to be compared. The
least abundant template was pIgR, and there was
approximately 10-fold more J-chain and α-chain in
the RNA samples. None of the No-RT control samples
for pIgR, α-chain, or J-chain produced a detectable
product.
There was no correlation with age, sex, or
histopathologic finding for any of the gene targets.
There was no significant difference in the expression of
pIgR, J-chain, or α-chain (P = 0.199, 0.330, and 0.712,
respectively, with the Kruskal-Wallis test) between the
3 groups of dogs (Figure 2).
Discussion
There was variation among the individual dogs in
the expression levels of mRNA encoding pIgR, J-chain,
or α-chain, but the ranges of values were similar
among the 3 groups. Furthermore, there was no differ-
ence in the level of expression of mRNA for these 3 tar-
get transcripts between dogs with and without diarrhea
or between dogs of different breeds. However, RNA can
undergo posttranscriptional regulation; within a cell,
RNA can be translationally active or inactive and can
vary in its stability. Therefore, it is well recognized that
the level of expression for a particular protein may not
necessarily reflect the amount of mRNA encoding it.40,41
Yet results of in vitro studies have indicated that the
protein expressions of human pIgR42 and α-chain43 do
correlate with their mRNA expressions. Therefore, the
lack of a difference in the level of expression of mRNA
for the 3 target transcripts among dogs of different
breeds and among dogs with and without diarrhea
probably reflects a similar lack of difference in the
expression of these proteins.
The wide variation in expression of the transcripts
among dogs may be a consequence of the method of
sample collection because biopsy specimens obtained
endoscopically are usually superficial and generally do
not include a standard ratio of crypt to villous tissue.
The number of IgA+ plasma cells within the duodenal
mucosa of dogs is greater in the pericrypt regions,
compared with the number in the villus lamina pro-
pria44; therefore, biopsy specimens with greater
amounts of crypt material will have larger numbers of
this type of cell. The depth of the biopsy specimen
could also affect the amount of pIgR mRNA because, in
humans, there is greater expression of this molecule by
the epithelial cells of the crypt region.15 In the present
study, this variation in the nature of the tissue sample
was minimized by collecting samples by use of 1 type
of biopsy forceps from a consistently designated area of
the duodenum. Moreover, collection of biopsy speci-
mens was generally performed by 1 endoscopist.
Grossly undersized or poor-quality biopsy specimens
were discarded. The variation in J-chain mRNA expres-
sion may reflect the relatively larger number of cell
types in which this molecule is expressed, including
IgA, IgM, and IgG plasma cells.45–48
Our study was restricted to the investigation of
duodenal mucosa because the samples were obtained
during endoscopic examination of the upper portion of
the gastrointestinal tract as part of clinical investiga-
tion of client-owned animals. The greatest number of
IgA+ plasma cells is present in the lamina propria of the
duodenum and colon in dogs, with fewer cells in the
more distal regions of the small intestine.44,49,50 Peyer’s
patches contain populations of plasma cells, including
IgA+ plasma cells,51 and could have been used to exam-
ine α-chain and J-chain expression; however, M cells
do not express pIgR and therefore do not participate in
pIgR-mediated transport of IgA.52 Duodenal mucosa
was also selected, as previous studies in which a rela-
tive deficiency in gastrointestinal mucosal IgA secre-
tion in German Shepherd Dogs was detected used duo-
denal luminal fluid29 and duodenal explant cultures.36
Compared with similar cells from clinically nor-
mal humans, peripheral blood mononuclear cells from
IgA-deficient humans produce minimal amounts of α-
chain mRNA when stimulated in vitro by anti-CD40
antibody.53 In the present study, there was no evidence
of decreased α-chain mRNA production in German
Shepherd Dogs with chronic diarrhea, compared with
production in non-German Shepherd Dogs with or
without chronic diarrhea, which does not support the
presence of this type of simple genetic abnormality in
dogs of this breed.
Our data have indicated that mRNA transcripts for
pIgR, α-chain, and J-chain in biopsy specimens of duo-
denal mucosa obtained endoscopically from dogs can
be quantified by QRT-PCR procedures. However, no
evidence was found of a simple deficiency of any of
these transcripts in the intestinal mucosa of German
Shepherd Dogs with diarrhea, compared with dogs of
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Figure 2—Plots of the relative copy number assessed via QRT-
PCR assays for polymeric immunoglobulin receptor (pIgR), J-
chain, and α-chain templates in duodenal biopsy specimens
obtained from 9 non-German Shepherd Dogs without diarrhea
(group 1), 27 non-German Shepherd Dogs with diarrhea (group
2), and 12 German Shepherd Dogs with diarrhea (group 3). The
horizontal line corresponds to the median value of that group.
The sample with a relative copy number of 0 had no detectable
J-chain template. In the expression of pIgR, J-chain, or α-chain,
there were no significant differences among the groups.
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other breeds with or without diarrhea. These observa-
tions do not rule out the possibility of a deficiency in
the amount of synthesized protein or a mutated
nucleotide sequence affecting the function of the
encoded protein, but there is no evidence that lack of
gene transcription plays a role in the disease suscepti-
bility of this breed.
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b. FB-25K, Olympus Keymed, Southend-on-Sea, UK.
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d. Invitrogen Ltd, Paisley, Scotland.
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g. SV total RNA isolation system, Promega Corp, Madison, Wis.
h. Platinum quantitative RT-PCR thermoscript one-step system,
Invitrogen Ltd, Paisley, Scotland.
i. Sigma-Aldrich Ltd, Poole, Dorset, UK.
j. Thermofast, Abgene, Epsom, Surrey, UK.
k. Platinum Taq DNA polymerase, Invitrogen Ltd, Paisley,
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Appendix
Combinations of forward and reverse primers and probe sequences used to measure mRNA encoding glyceraldehyde-3-phosphate
dehydrogenase (G3PDH), polymeric immunoglobulin receptor (pIgR), the J-chain, and the α-chain, in duodenal mucosa from dogs with
and without chronic diarrhea by use of quantitative real-time reverse transcription-polymerase chain reaction assays.
Target Forward primer* Reverse primer* 5’ Fluorophore Probe Sequence† 3’ Quencher Product length (bp)
G3PDH TCAACGGATTTGGCCGTATTGG TGAAGGGGTCATTGATGGCG Hex CAGGGCTGCTTTTAACTCTGGCAAAGTGGA BHQ-1 90
pIgR ATCACCAACTTCCCAGACAG TAATGCCCAGACCACACTTAT CY5 GTGATGAACATTGACCACCTCACCCAG BHQ-2 94
J-Chain TCTGATCCCACCTCACCAGT TGCGAGGCAATAACTACTTGA SYBR Green I 113
α−chain CGTCTGTGAAATGCCAAGTG AGGGCTGGCTTCTGTAGTGA SYBR Green I 136
*All primers were desalted when purified. †The probes were purified via high-pressure liquid chromatography.
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